This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Medical Education  • Alert me on articles by topic  Social Bookmarking   What's this?

Robert Steinbrook, MD

JAMA. 2008;299(9):1060-1062.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Continuing medical education (CME) is a multibillion-dollar industry. In 2006, the CME providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) had a total income of $2.38 billion.¹ In 1998, the income was $889 million, and most had come from the registration fees of participants or sponsoring organizations. Since 2003, however, most of the income for CME providers has come from industry.²

Commercial support for CME accredited by the ACCME quadrupled between 1998 and 2006–from $302 million to $1.2 billion–and doubled from other sources.¹ In 2006, the combined for-profit support (commercial support and advertising and exhibit income) represented 60.6% of total income. An industry magazine stated in its annual medical education report: "For continuing education to continue, commercial funding must remain healthy. The future of CME depends on it."³

The profit margin for ACCME-accredited providers increased from 5.5% in 1998 to 31.0% in 2006.¹ The . . . [Full Text of this Article]

Funding for Different Types of CME Organizations

Author Affiliations: Dartmouth Medical School, Hanover, New Hampshire; and Veterans Affairs Outcomes Group, White River Junction, Vermont.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Experts Debate Need to Improve Quality and Oversight of Continuing Education
Tracy Hampton
JAMA. 2008;299(9):1003-1004.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reform of Continuing Medical Education: Investments in Physician Human Capital
Campbell and Rosenthal
JAMA 2009;302:1807-1808.
FULL TEXT  

Pharmacists' role in facilitating evidence-based prescribing for unlabeled use of medications
Macaulay et al.
Am J Health Syst Pharm 2009;66:1735-1739.
FULL TEXT  

Off-label prescribing: a call for heightened professional and government oversight.
Dresser and Frader
J Law Med Ethics 2009;37:476-486.
 

Controlling Conflict of Interest -- Proposals from the Institute of Medicine
Steinbrook
NEJM 2009;360:2160-2163.
FULL TEXT  

Professional Medical Associations and Their Relationships With Industry: A Proposal for Controlling Conflict of Interest
Rothman et al.
JAMA 2009;301:1367-1372.
ABSTRACT | FULL TEXT  

Vulnerability in clinical research with patients in pain: a risk analysis.
Tait
J Law Med Ethics 2009;37:59-72.
 

Perspectives on Continuing Education in the Health Professions: Improving Health Care Through Lifelong Learning
Leach and Fletcher
Chest 2008;134:1299-1303.
ABSTRACT | FULL TEXT  

Industry Support of Medical Education
Relman
JAMA 2008;300:1071-1073.
FULL TEXT  

Commercialism, Loss of Professionalism, and the Effect on Journals
Liesegang
Arch Ophthalmol 2008;126:1292-1295.
FULL TEXT  

A Historical Perspective of Pharmaceutical Promotion and Physician Education
Podolsky and Greene
JAMA 2008;300:831-833.
FULL TEXT  

Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence
DeAngelis and Fontanarosa
JAMA 2008;299:1833-1835.
FULL TEXT